Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Estriol/lactobacillus - Acerus Pharmaceuticals/Medinova

Drug Profile

Estriol/lactobacillus - Acerus Pharmaceuticals/Medinova

Alternative Names: Estriol-Lactobcillus acidophilus mixt. - Acerus/Medinova; Estriol/lyophilised lactobacilli - Acerus/Medinova; Gynoflor; Ultra-low dose estrogen/lactobacillus - Acerus/Medinova

Latest Information Update: 21 May 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Medinova
  • Developer Acerus Pharmaceuticals; Medinova
  • Class Estrenes; Hormonal replacements; Probiotics
  • Mechanism of Action Estrogen receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Registered Atrophic vaginitis; Infections

Most Recent Events

  • 11 Apr 2018 Acerus Pharmaceuticals Corporation responds to a Notice of Deficiency from Health Canada for Estriol/lactobacillus in Atrophic vaginitis
  • 24 Dec 2017 Acerus Pharmaceuticals Corporation receives a Notice of Deficiency from Health Canada for Estriol/lactobacillus in Atrophic vaginitis
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top